PMID: 7017917Jan 1, 1981Paper

Additive clinical effect of indomethacin suppositories during salicylate therapy in rheumatoid patients

Scandinavian Journal of Rheumatology
R EkstrandA Rane

Abstract

Twelve rheumatic patients were given 2.0 and 4.5 g acetylsalicylic acid daily in two 3-week periods. On days 13 and 20 of each period the patients took a suppository containing either placebo or 50 mg of indomethacin. The study was performed double-blind. Indomethacin had a significant additive effect during ASA therapy with 2 g daily as estimated by articular index and subjective ratings of pain and morning stiffness. On the 4.5 g ASA dose there was a significant improvement only for articular index. The patients experienced less pain during maintenance therapy with 4.5 g of ASA compared with 2.0 g daily. Both ASA doses induced complete inhibition of prostaglandin PGF2 alpha release from platelets. Thus the suppression of PGF2 alpha release does not reflect the therapeutic response of these drugs. Side effects observed comprised tinnitus, dizziness and gastritis. In 2 of the patients the aminotransferase levels increased, indicating hepatotoxicity. The protein binding of salicylate decreased with increasing salicylate concentration. As the dose was increased from 2.0 to 4.5 g/day the unbound concentration increased 5 to 24 times. This reflects the combined effect of capacity-limited metabolism and capacity-limited protein bind...Continue Reading

References

Mar 1, 1979·Clinical Pharmacokinetics·R EkstrandO Borga
Nov 1, 1979·British Journal of Clinical Pharmacology·D M GrennanM Mackinnon
Sep 1, 1979·Clinical Pharmacology and Therapeutics·D E FurstK L Melmon
Jan 1, 1977·Scandinavian Journal of Rheumatology·L E TrangO Lövgren
Oct 1, 1976·Clinical Pharmacology and Therapeutics·O BorgåA Norlin
Jul 12, 1975·British Medical Journal·P M BrooksA R Rhymer
Sep 1, 1975·The Journal of Clinical Investigation·G J Roth, P W Majerus
Aug 14, 1975·European Journal of Clinical Pharmacology·C R JoyceR M Mason
Nov 1, 1972·Biochemical and Biophysical Research Communications·M Hamberg
Nov 1, 1972·European Journal of Clinical Investigation·M L WahlqvistL A Carlson
Jun 23, 1971·Nature: New Biology·J B Smith, A L Willis
Jul 1, 1966·Annals of the Rheumatic Diseases·D A PitkeathlyJ Sharp
Mar 2, 1967·The New England Journal of Medicine·R S Pinals, S Frank
Sep 1, 1968·The Journal of Clinical Investigation·H J WeissS Kochwa
Jul 1, 1965·Journal of Pharmaceutical Sciences·G Levy
Jun 1, 1980·European Journal of Clinical Pharmacology·R EkstrandB Sarby

❮ Previous
Next ❯

Citations

Jun 1, 1981·British Journal of Clinical Pharmacology·G AlvánL L Gustafsson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrophic Gastritis

Atrophic Gastritis is a process where gastric glandular cells are lost and replaced with firbous tissues, as a result of chronic inflammation. Learn more about Atrophic Gastritis here.